Sue Bailey, Director at Emergent BioSolutions Inc. (EBS), sold 19,906 shares at $29.78 ($593K) on 2017-01-17, disclosed to the SEC on 2017-01-19.
Open-market sale of $593k EBS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.78 | 2,061 | $61K | 10.4% |
| 2 | $29.78 | 3,157 | $94K | 15.9% |
| 3 | $29.78 | 4,735 | $141K | 23.8% |
| 4 | $29.78 | 2,061 | $61K | 10.4% |
| 5 | $29.78 | 3,157 | $94K | 15.9% |
| 6 | $29.78 | 4,735 |
| $141K |
| 23.8% |
| Total | $29.78 avg | 19,906 | $593K | 100% |
| Filing → |
| EBS | SELL | 2020-06-05 | $466K | — | Filing → |
| EBS | SELL | 2020-03-02 | $748K | — | Filing → |
| EBS | SELL | 2019-12-13 | $895K | — | Filing → |